期刊文献+

白细胞介素-11在自身免疫病中的研究进展 被引量:1

下载PDF
导出
摘要 自身免疫病(AD)是指机体对自身抗原发生免疫反应而导致自身组织损害所引起的疾病,严重影响人类生活水平。迄今为止国内外有报道的AD约有30多种,其中大部的发病机制尚未完全阐明。目前细胞因子网络失衡在AD发病中的作用是国内外热门研究课题。IL-11作为一种新型多效性细胞因子,近年来受到研究者们的共同关注,明确其在多种AD中的作用,可能为疾病的靶向治疗提供相关参考价值。现就近年来IL-11在AD中的研究进展进行综述。
作者 李琳 苏娟
出处 《实用医学杂志》 CAS 北大核心 2015年第21期3610-3612,共3页 The Journal of Practical Medicine
基金 中西部高校综合实力提升工程建设项目:血液病学教学科研创新团队建设(编号:4056051001) 青海省2015年科技创新能力促进计划项目(编号:2015-HZ-810)
  • 相关文献

参考文献26

  • 1Jazayeri JA, Carroll GJ, Vernallis AB. Interleukin-6 subfamily eytokines and rheumatoid arthritis: role of antagonists [ J]. Int Immunopharmacol, 2010, 10( 1 ) : 1-8.
  • 2Putoczki T, Ernst M. More than a sidekick: the IL-6 family cy- tokine IL-11 links inflammation to cancer [ J ]. J Leuko Biol, 2010,88(6) : 1109-1117.
  • 3Peterson H, Abu Dawud R, Garg A, et al. Qualitative modeling identifies IL-11 as a novel regulator in maintaining self-renewal in human pluripotent stem cells [J]. Front Physiol, 2012, 4: 303.
  • 4Ernst M, Thiem S, Nguyen PM, et al. Epithelial gp130/Stat3 functions: An intestinal signaling node in health and disease [J]. Semin Immunol, 2014,26 ( 1 ): 29- 37.
  • 5Aitsebaomo J, Srivastava S, Zhang H, et al. Recombinant hu- man intedeukin-ll treatment enhances collateral vessel growth after femoral artery ligation [J].Arterioseler Thromb Vase Biol, 2011,31 (2) :306-312.
  • 6McCoy EM, Hong H, Pruitt HC, et al. IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells [J]. BMC Cancer, 2013,13 (1):16.
  • 7Souza PPC, Lemer UH. The role of cytokines in inflammatory bone loss [J]. Immunol Investigat, 2013,42(7) :555-622.
  • 8Elsaeidi F, Bemben MA, Zhao XF, et al. Jak/Stat signaling stimulates zebrafish optic nerve regeneration and overcomes the inhibitory actions of Sots3 and Sfpq [J]. J Neurosci, 2014,34 (7) : 2632-2644.
  • 9Menkhorst E, Salamonsen L, Robb L, et al. IL11 antagonist in- hibits uterine stromal differentiation, causing pregnancy failure in mice [ J ]. Biol Reprod, 2009,80 (5) : 920-927.
  • 10Kheifetz Y, Elishmereni M, Agur Z. Complex pattern of inter- leukin-ll-induced inflammation revealed by mathematically modeling the dynamics of C-reactive protein [J]. J Pharma- cokinet Pharmacodyn, 2014,41(5) :479-491.

二级参考文献44

  • 1徐亮,王元,陈顺乐,沈南.系统性红斑狼疮血小板减少患者巨核祖细胞分化障碍[J].上海医学,2004,27(10):739-742. 被引量:17
  • 2Feinglass S, Deodhar A. Treatment of lupus-induced thrombocytopenia with recombinant human interleukin-ll [J]. Arthritis Rheum, 2001,44( 1 ) : 170-175.
  • 3Terpos E, Dimopouios MA, Sezer O, et al. The use of bio- chemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group [ J]. Leukemia, 2010, 24 : 1700-1712.
  • 4Tesch G, Amur S, Schousboe JT, et al. Successes a-chieved and challenges ahead in translating biomarkers into clinical applications [ J]. AAPS J, 2010, 12 : 243- 253.
  • 5Wistowska M, Jakubicz D, Stepiefi K, et al. Serum con- centrations of formation (PINP) and resorption (CTX) bone turnover markers in rheumatoid arthritis [ J ]. Rheu- matol Int, 2009, 29 : 1403-1409.
  • 6Syversen SW, Goll GL, van der Heijde D, et al. Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression [ J]. J Rheumatol, 2009, 36 : 266-272.
  • 7Syversen SW, Haavardshohn EA, Boyeseno, et al. Bio- markers in early rheumatoid arthritis: longitudinal associa- tions with inflammation and joint destruction measured by magnetic resonance imaging and conventional radiographs [J]. Ann Rheum Dis, 2010, 69: 845-850.
  • 8Van Tuyl LH, Voskuyl AE, Boers M, et al. Baseline RANKL: OPG ratio and markers of bone and cartilage deg- radation predict annual radiological progression over 11 years in rheumatoid arthritis [ J]. Ann Rheum Dis, 2010, 69 : 1623-1628.
  • 9Sassi ML, Aman S, Hakala M, et al. Assay for crosslinked carboxy terminal telopeptide of type I collagen (ICTP) unlike crosslaps assay reflects increased pathologi- cal degradation of type I collagen in rheumatoid arthritis [J]. Clin Chem Lab, 2003, 41: 1038-10rid.
  • 10HakaIal M, Risteli J, Aman S, et al. Combination drug strategy in recent-onset rheumatoid arthritis suppresses col- lagen I degradation and is associated with retardation of ra- diological progression [ J ]. Scand J Rheumatol, 2008, 37 : 90-93.

共引文献22

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部